Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused